LifeStance Health gains as Hedgeye adds as new long idea
LifeStance Health (LFST) shares surged by 14% after Hedgeye identified it as a new long idea, projecting a potential upside of 32-60%. Hedgeye analyst Tom Tobin noted that the company's core business is outperforming consensus expectations across all three key revenue drivers.